Dr. Ling is an Associate Professor of Radiation Oncology at the University of Rochester Medical Center. She received a B.A. in Biology from Williams College in 1983. The Following year, she was awarded a Certificat de Merité from the Cordon Bleu Académie Cuisine in Paris, France. She then enrolled at the University of Maryland and received her M.D. in 1988, which was followed by residency at Johns Hopkins Hospital. From 1992 to 1996, Dr. Ling relocated to the Boston area, where she was an instructor and then Assistant Professor in Radiation Oncology at Tufts University School of Medicine and New England Medical Center. She was also a visiting scientist at the Massachusetts Institute of Technology's Nuclear Research Laboratory. From 1997 to 1999, Dr. Ling was a Clinical Assistant Professor at the University of Washington Medical Center in Seattle. In 1999, Dr. Ling moved back east and joined the faculty at the University of Rochester. She is board-certified by the American College of Radiology and is Co-Medical Director of the Integrative Oncology and Wellness Center.

Dr. Ling's interests and publications have covered topics relating to breast cancer such as the latest radiation treatment modalities (stereotactic body radiotherapy, intensity modulated radiotherapy), breast conserving therapy and reconstruction, and side effects of treatment (bone loss, nausea, radiation dermatitis, fatigue). She has also been an invited speaker at special events hosted by local breast cancer support organizations. Dr. Ling is a member of the American Society for Therapeutic Radiology and Oncology. She also received board certification from the American Board of Integrative and Holistic Medicine.

Certified Specialties

Radiation Oncology - American Board of Radiology

Faculty Appointments

Associate Professor of Clinical Radiation Oncology - Department of Radiation Oncology (SMD)

Credentials

Residency & Fellowship

Residency, Radiation Oncology, Johns Hopkins Hospital. 1989 - 1992

Internship, Internal Medicine, Lenox Hill Hospital. 1988 - 1989

Education

MD | University of Maryland School of Medicine. 1988

Awards

Angel Award. 2016

Jacob Gitelman Award. 2016

Heart & Hands Award. 2013

Rubin-Mitchell Teaching Award. 2004

Publications

Journal Articles

Risk stratification of ER-positive breast cancer patients: A multi-institutional validation and outcome study of the Rochester Modified Magee algorithm (RoMMa) and prediction of an Oncotype DX® recurrence score <26

Turner BM; Gimenez-Sanders MA; Soukiazian A; Breaux AC; Skinner K; Shayne M; Soukiazian N; Ling M; Hicks DG.

Cancer Med. 2019; 8(9): 4176-4188.

The effects of high-dose calcitriol and individualized exercise on bone metabolism in breast cancer survivors on hormonal therapy: a phase II feasibility trial.

Peppone LJ, Ling M, Huston AJ, Reid ME, Janelsins MC, Puzas JE, Kamen C, Del Giglio A, Asare M, Peoples AR, Mustian KM

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer.. 2018 August 26 (8):2675-2683. Epub 02/22/2018.

Oral curcumin for radiation dermatitis: a URCC NCORP study of 686 breast cancer patients.

Ryan Wolf J, Heckler CE, Guido JJ, Peoples AR, Gewandter JS, Ling M, Vinciguerra VP, Anderson T, Evans L, Wade J, Pentland AP, Morrow GR

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer.. 2018 May 26 (5):1543-1552. Epub 12/01/2017.

Use of modified Magee equations and histologic criteria to predict the Oncotype DX recurrence score.

Turner BM, Skinner KA, Tang P, Jackson MC, Soukiazian N, Shayne M, Huston A, Ling M, Hicks DG

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.. 2015 July 28 (7):921-31. Epub 05/01/2015.

Curcumin for radiation dermatitis: a randomized, double-blind, placebo-controlled clinical trial of thirty breast cancer patients.

Ryan JL, Heckler CE, Ling M, Katz A, Williams JP, Pentland AP, Morrow GR

Radiation research.. 2013 July 180 (1):34-43. Epub 06/07/2013.

Polarity therapy for cancer-related fatigue in patients with breast cancer receiving radiation therapy: a randomized controlled pilot study

Mustian KM; Roscoe JA; Palesh OG; Sprod LK; Heckler CE; Peppone LJ; Usuki KY; Ling MN; Brasacchio RA; Morrow GR.

Integr Cancer Ther. 2011; 10(1): 27-37.

Irradiated autologous breast reconstructions: effects of patient factors and treatment variables.

Albino FP, Koltz PF, Ling MN, Langstein HN

Plastic and reconstructive surgery.. 2010 July 126 (1):12-6. Epub 1900 01 01.

The efficacy of calcitriol therapy in the management of bone loss and fractures: a qualitative review.

Peppone LJ; Hebl S; Purnell JQ; Reid ME; Rosier RN; Mustian KM; Palesh OG; Huston AJ; Ling MN; Morrow GR.

Osteoporos Int. 2010; 21(7): 1133-49.

Angiosarcoma of the breast: a rare clinicopathological entity.

Biswas T, Tang P, Muhs A, Ling M

American journal of clinical oncology.. 2009 December 32 (6):582-6. Epub 1900 01 01.

Acupressure bands are effective in reducing radiation therapy-related nausea.

Roscoe JA, Bushunow P, Jean-Pierre P, Heckler CE, Purnell JQ, Peppone LJ, Chen Y, Ling MN, Morrow GR

Journal of pain and symptom management.. 2009 September 38 (3):381-9. Epub 03/28/2009.

A non-invasive immobilization system and related quality assurance for dynamic intensity modulated radiation therapy of intracranial and head and neck disease.

Tsai JS, Engler MJ, Ling MN, Wu JK, Kramer B, Dipetrillo T, Wazer DE

International journal of radiation oncology, biology, physics.. 1999 January 1543 (2):455-67. Epub 1900 01 01.

Dosimetric verification of the dynamic intensity-modulated radiation therapy of 92 patients.

Tsai JS, Wazer DE, Ling MN, Wu JK, Fagundes M, DiPetrillo T, Kramer B, Koistinen M, Engler MJ

International journal of radiation oncology, biology, physics.. 1998 March 1540 (5):1213-30. Epub 1900 01 01.

Dosimetric comparison of stereotactic radiosurgery to intensity modulated radiotherapy.

Kramer BA, Wazer DE, Engler MJ, Tsai JS, Ling MN

Radiation oncology investigations. 1998 6 (1):18-25. Epub 1900 01 01.

A technique for accurate planning of stereotactic brain implants prior to head ring fixation.

Ulin K, Bornstein LE, Ling MN, Saris S, Wu JK, Curran BH, Wazer DE

International journal of radiation oncology, biology, physics.. 1997 October 139 (3):757-67. Epub 1900 01 01.

Response of intracranial melanoma metastases to stereotactic radiosurgery.

Gieger M, Wu JK, Ling MN, Wazer D, Tsai JS, Engler MJ

Radiation oncology investigations. 1997 5 (2):72-80. Epub 1900 01 01.

Radiation therapy of external iliac lymph nodes with lateral pelvic portals: identification of patients at risk for inadequate regional coverage.

Chun M, Timmerman RD, Mayer R, Ling MN, Sheldon J, Fishman EK

Radiology.. 1995 January 194 (1):147-50. Epub 1900 01 01.

A model system that predicts effective half-life for radiolabeled antibody therapy.

Klein JL, Ling MN, Leichner PK, Kopher KA, Rostock RA, Order SE

International journal of radiation oncology, biology, physics.. 1985 August 11 (8):1489-94. Epub 1900 01 01.

Books

Radiosurgery 1995, Proceedings of the 2nd ISRS meeting, Boston, Massachusetts (1996)

Chapter: Preliminary Clinical Experience with the Peacock Intensity Modulation 3-D Conformal Radiation Therapy System.

Authors: Carol M. Grossman R, Selker R, Polk D, Wu J, Butler B, Woo S, Wisenberg M, Figura J, Onufrey V, Wazer D, Ling MN, Grant W. Pavord D, Turner A, Berta C, Engler M, Tsai JS, Curran B, Kania A, Larson S, Tracey L:

Publisher: Karger, Basel 1996

Ratings & Reviews

At URMC, we believe that patients should be empowered to make the right decisions regarding their personal healthcare. To do so, transparency is critical. URMC partners with Press Ganey, to survey our patients about all aspects of their care experience. We are now putting this pertinent information at your fingertips by displaying star ratings for our providers along with anonymous patient comments on our website. This will help you make better-informed choices about how and with whom you seek care. Click here to learn more about the surveys used to generate this vital information. Learn more about our survey process.